DarioHealth Corp. (DRIO)
| Market Cap | 51.92M +88.8% |
| Revenue (ttm) | 21.19M -24.4% |
| Net Income | -41.76M |
| EPS | -8.29 |
| Shares Out | 7.31M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 12,089 |
| Open | 7.78 |
| Previous Close | 7.50 |
| Day's Range | 7.02 - 7.78 |
| 52-Week Range | 5.85 - 17.74 |
| Beta | 1.09 |
| Analysts | Buy |
| Price Target | 15.25 (+114.79%) |
| Earnings Date | Aug 13, 2026 |
About DRIO
DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the sympt... [Read more]
Financial Performance
In 2025, DarioHealth's revenue was $22.36 million, a decrease of -17.31% compared to the previous year's $27.04 million. Losses were -$40.31 million, 34.0% more than in 2024.
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for DRIO stock is "Buy." The 12-month stock price target is $15.25, which is an increase of 114.79% from the latest price.
News
DarioHealth launches integrated GLP-1 Program
DarioHealth (DRIO) announced the launch of Dario’s Integrated GLP-1 Program, the first commercial offering built on the company’s recently announced collaboration with Beluga Health. Dario has support...
DarioHealth prices 3.45M shares at $6.80 in registered direct offering
DarioHealth (DRIO) announced that it has entered into securities purchase agreements with current long term Dario institutional investors as well as new fundamental investors for the purchase and sale...
Dario Announces Pricing of a $23.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
The financing was led by continued support of existing long-term institutional investors along with participation from a new global fundamental institutional investor NEW YORK, July 22, 2026 /PRNewswi...
DarioHealth trading halted, volatility trading pause
09:41 EDT DarioHealth (DRIO) trading halted, volatility trading pause
DarioHealth selected to deliver AI-powered cardiometabolic care platform
DarioHealth (DRIO) announced another Fortune 50 employer has selected Dario to provide its integrated digital cardiometabolic care platform for employees living with diabetes and/or hypertension. The ...
Fortune 50 Employer Awards Dario Contract to Deliver AI-Powered Cardiometabolic Care Platform
Contract award for over 100,000 eligible employees marks Dario's fifth Fortune 50 client, further reflecting growing demand among large employers for integrated, outcomes-driven chronic condition mana...
DarioHealth expects DarioIQ to increase B2B2C recurring revenue by 10%-15%
DarioHealth (DRIO) announced the company expects broader deployment of DarioIQ, its proprietary, responsible generative and agentic AI platform, to increase annual Business-to-Business-to-Consumer rec...
Dario Expects Proprietary AI Engine DarioIQ™ to Increase Recurring Revenue from Existing Customers by 10-15%
DarioIQ drives higher engagement and retention, better clinical outcomes, higher client ROI and recurring revenue growth for Dario Dario IQ's AI-driven personalization increases member engagement by 4...
DarioHealth Slides: Corporate presentation
DarioHealth has posted slides in relation to its latest quarterly earnings report, which was published on July 11, 2026.
DarioHealth signs new agreement with health insurer in Arizona
DarioHealth (DRIO) announced a new agreement with a major health insurer with a stronghold in Arizona, entered into through its strategic channel partnership with Amwell. This opportunity makes Dario’...
Dario Signs New Agreement with a Major Health Insurer in Arizona Representing Hundreds of Thousands of Lives Through Amwell Partnership
Agreement representative of Dario's channel-led growth strategy to bring cardiometabolic digital health solution at scale to self-insured employers seeking measurable reductions in cardiometabolic ris...
DarioHealth’s hypertension solution added to agreement with health insurer
DarioHealth (DRIO) announced that one of the 5 largest health insurers in the U.S. has extended its initial agreement and expanded its relationship with Dario by adding the company’s hypertension…
Top National Health Plan Extends Agreement for Mental Health and Expands Dario Partnership into Cardiometabolic Care, Demonstrating Successful Multi-Condition Growth Strategy
Third health plan customer to expand beyond initial deployment, reinforcing Dario's land-and-expand strategy and creating significant opportunity to grow revenue within existing customer base NEW YORK...
Dario Appoints Former Humana Chief Compliance Officer Sean O'Reilly to Advisory Board to Support Strategic Growth and Healthcare Partnerships
O'Reilly's extensive experience across healthcare compliance, risk management, regulatory oversight and payer operations expected to support Dario's continued expansion with health plans, employers an...
DarioHealth announces strategic collaboration with Beluga Health
DarioHealth (DRIO) announced it has entered into a Collaborative Services Agreement with Beluga Health, establishing a strategic partnership to deliver a provider-backed, digitally-enabled model for l...
Dario Announces Strategic Collaboration with Beluga Health to Deliver Provider-Backed, Integrated Care at Scale
Dario's best-in-class, consumer-centric chronic care platform, combined now with Beluga's embedded clinical delivery, extends member engagement to include provider-delivered treatment, lowering costs ...
Dario Presents Four Studies at American Diabetes Association Scientific Sessions Highlighting Commercial and Clinical Value of its Digital Health Platform
Data from a total of 27 studies presented at ADA over 8 years reinforce Dario's strategic move closer to care, expanding revenue model into claims-based and outcomes-driven payments serving health pla...
Dario More Than Doubles Addressable Market in Solera Health's Network via Expanded Hypertension Program, With Dario Now Reaching Greater Than 500,000 Eligible Lives
Expansion driven by highly successful partnership based on Dario's consistent ability to engage members and deliver scalable value across cardiometabolic conditions NEW YORK, May 26, 2026 /PRNewswire/...
DarioHealth Earnings Call Transcript: Q1 2026
Sequential revenue growth and reduced operating expenses marked Q1 2026, with expanded channel partnerships and a strong commercial pipeline. Strategic moves into care delivery and outcomes-based models are expected to drive future growth.
DarioHealth Quarterly report: Q1 2026
DarioHealth has published its Q1 2026 quarterly earnings report on May 13, 2026.
DarioHealth Earnings release: Q1 2026
DarioHealth released its Q1 2026 earnings on May 13, 2026, summarizing the period's financial results.
DarioHealth Slides: Q1 2026
DarioHealth has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 13, 2026.
DarioHealth reports Q1 EPS ($1.25), consensus (85c)
Reports Q1 revenue $5.58M, consensus $5.46M. “The first quarter of 2026 was our second consecutive quarter of sequential revenue growth, alongside continued reductions in operating expenses. Our chann...
DarioHealth Reports First Quarter 2026 Financial and Operating Results
First quarter 2026 revenues increased to $5.6 million, marking the second consecutive quarter of sequential growth Operating expenses decreased by 21% year-over-year and decreased by 8% quarter-over-q...